US2021008009A1PendingUtilityA1

Gene expression regulating agent

Assignee: FUJI CHEM IND CO LTDPriority: Feb 4, 2004Filed: Sep 30, 2020Published: Jan 14, 2021
Est. expiryFeb 4, 2024(expired)· nominal 20-yr term from priority
A61P 1/10A61K 31/122A61P 35/00A61P 25/28A61P 27/02A61P 1/04A61P 3/04A61P 37/08A61P 13/02A23L 33/10A61P 3/06A61P 7/00A61P 25/02A61P 21/00A61P 1/18A61P 43/00A23V 2002/00A61P 1/12A61P 9/12A61P 29/00A61K 31/21A23L 2/52A61P 19/06A61P 27/06A61P 27/12A61P 21/04A61P 3/10A23L 33/105A61P 13/12A61P 27/16A61P 11/00A61P 9/10
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An object of the invention is to provide a gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester. Abnormal gene expression due to, for example, oxidative stress can be treated, improved, and/or prevented, and diseases caused by the abnormal gene expression can be treated, improved, and/or prevented. A gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester are provided and are useful for treating, improving, and/or preventing the symptom caused by the abnormal gene expression, that is, excessive expression or suppression of expression.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for reducing muscle atrophy in a subject having muscle atrophy, comprising administering to the subject at least one of the group consisting of isolated astaxanthin and an ester thereof as an effective ingredient. 
     
     
         2 . The method according to  claim 1 , wherein the at least one of the group consisting of astaxanthin and an ester thereof is administered as an effective ingredient in the form of a food or a drink.

Join the waitlist — get patent alerts

Track US2021008009A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.